Ainos, Inc. (AIMD)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Mar 12, 2025

$0.46

P/E Ratio

N/A

Market Cap

$7.1M

Loading...
Description
Add to research

Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. Its medtech solutions include COVID-19 Antigen Rapid Test Kit, VOC POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, Very Low-Dose Oral Interferon Alpha, and Synthetic RNA. The company was founded on June 26, 1984 and is headquartered in San Diego, CA.

Metrics
Add to research

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerAIMD
  • Price$0.46-2.02%

Trading Information

  • Market cap$7.10M
  • Float32.19%
  • Average Daily Volume (1m)249,547
  • Average Daily Volume (3m)691,095
  • EPS-$1.56

Company

  • Revenue$0.02M
  • Rev growth (1yr)-83.02%
  • Net income-$14.86M
  • Gross margin-23,317.97%
  • EBITDA margin-43,607.89%
  • EBITDA-$9.04M
  • EV$12.44M
  • EV/Revenue600.16
  • P/EN/A
  • P/S210.90
  • P/B0.46
  • Debt/Equity77.34
Documents
Add to research
Loading...